Meka Arjun Prasad, Porath Jonathan Douglas, Iyengar Rahul, Morrow Chelsea, Fagerlin Angela, Meurer William J
University of Michigan Medical School, Ann Arbor, MI.
Department of Population Health Sciences, University of Utah, Salt Lake City, UT.
Acad Emerg Med. 2017 Jun;24(6):686-690. doi: 10.1111/acem.13148. Epub 2017 Mar 17.
While diagnostic testing is common in the emergency department, the value of some testing is questionable. The purpose of this study was to assess how varying levels of benefit, risk, and costs influenced an individual's desire to have diagnostic testing.
A survey through Amazon Mechanical Turk presented hypothetical clinical situations: low-risk chest pain and minor traumatic brain injury. Each scenario included three given variables (benefit, risk, and cost), that was independently randomly varied over four possible values (0.1, 1, 5, and 10% for benefit and risk and $0, $100, $500, and $1,000 for the individual's personal cost for receiving the test). Benefit was defined as the probability of finding the target disease (traumatic intracranial hemorrhage or acute coronary syndrome).
One-thousand unique respondents completed the survey. With an increased benefit from 0.1% to 10%, the percentage of respondents who accepted a diagnostic test went from 28.4% to 53.1%. (odds ratio [OR] = 3.42; 95% confidence interval [CI] = 2.57-4.54). As risk increased from 0.1% to 10%, this number decreased from 52.5% to 28.5%. (OR = 0.33; 95% CI = 0.25-0.44). Increasing cost from $0 to $1,000 had the greatest change of those accepting the test from 61.1% to 21.4%, respectively (OR = 0.15; 95% CI = 0.11-0.2).
The desire for testing was strongly sensitive to the benefits, risks, and costs. Many participants wanted a test when there was no added cost, regardless of benefit or risk levels, but far fewer elected to receive the test as cost increased incrementally. This suggests that out-of-pocket costs may deter patients from undergoing diagnostic testing with low potential benefit.
虽然诊断检测在急诊科很常见,但一些检测的价值值得怀疑。本研究的目的是评估不同程度的益处、风险和成本如何影响个体进行诊断检测的意愿。
通过亚马逊土耳其机器人进行的一项调查呈现了假设的临床情况:低风险胸痛和轻度创伤性脑损伤。每个场景包含三个给定变量(益处、风险和成本),这些变量在四个可能值上独立随机变化(益处和风险为0.1%、1%、5%和10%,个体接受检测的个人成本为0美元、100美元、500美元和1000美元)。益处定义为发现目标疾病(创伤性颅内出血或急性冠状动脉综合征)的概率。
1000名不同的受访者完成了调查。随着益处从0.1%增加到10%,接受诊断检测的受访者百分比从28.4%升至53.1%。(优势比[OR]=3.42;95%置信区间[CI]=2.57 - 4.54)。随着风险从0.1%增加到10%,这一数字从52.5%降至28.5%。(OR = 0.33;95% CI = 0.25 - 0.44)。成本从0美元增加到1000美元时,接受检测的人变化最大,分别从61.1%降至21.4%(OR = 0.15;95% CI = 0.11 - 0.2)。
检测意愿对益处、风险和成本高度敏感。许多参与者在不增加成本时希望进行检测,无论益处或风险水平如何,但随着成本逐渐增加,选择接受检测的人要少得多。这表明自付费用可能会阻碍患者接受潜在益处低的诊断检测。